DarioHealth plans to use USD 23.5 million offering proceeds for working capital, investments and acquisitions
DRIO•Use of offering proceeds
DarioHealth plans to deploy net proceeds from a USD 23.5 million registered direct offering into working capital, investments, acquisitions, and general corporate purposes.
Closing timing and investor support
Closing is targeted for on or about July 23, 2026, subject to customary conditions.
The company said its positioning strategy centers on an AI-powered platform for managing multiple chronic conditions, supported by existing institutional investors and a new fundamental investor.
